Page 5 - Ripple Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ripple therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ripple Therapeutics Today - Breaking & Trending Today

Ripple Therapeutics Appoints Jonathan Talamo, M.D., to Board of Directors

Ripple Therapeutics Appoints Jonathan Talamo, M.D., to Board of Directors
ACCESSWIRE
04 May 2021, 22:05 GMT+10
TORONTO, ON / ACCESSWIRE / May 4, 2021 / Ripple Therapeutics Corporation ( Ripple ) a clinical stage, ophthalmology-focused developer of novel pharmaceuticals, is pleased to announce the appointment of Jonathan Talamo, M.D., to the Board of Directors. Dr. Talamo is internationally known as an ophthalmologist, innovator and consultant to industry with more than 25 years of experience in healthcare.
Dr. Talamo is the former Chief Medical Officer and Worldwide VP of Clinical and Medical Affairs at Johnson and Johnson Vision. Prior to that, he served as the Chief Medical Officer at Ocular Therapeutix, an ophthalmic drug delivery company, where he oversaw clinical development programs in multiple therapeutic areas, including post-cataract surgery inflammation, dry eye, allergy, glaucoma and retinal vascular diseases. ....

Jonathan Talamo , Julie Fotheringham , Tom Reeves , Ripple Therapeutics Corporation , Affairs At Johnson , Chief Medical Officer , Medical Affairs , Ocular Therapeutix , Ripple Therapeutics , Therapeutics Corporation , டோம் ரீவ்ஸ் , சிற்றலை சிகிச்சை நிறுவனம் , தலைமை மருத்துவ அதிகாரி , மருத்துவ வாழ்க்கைத்தொழில்கள் , சிற்றலை சிகிச்சை , சிகிச்சை நிறுவனம் ,

Ripple Therapeutics Appoints Jonathan Talamo, M.D., to Board of Directors

Ripple Therapeutics Appoints Jonathan Talamo, M.D., to Board of Directors
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.

Jonathan Talamo , Julie Fotheringham , Tom Reeves , Ripple Therapeutics Corporation , Affairs At Johnson , Chief Medical Officer , Medical Affairs , Ocular Therapeutix , Ripple Therapeutics , Therapeutics Corporation , டோம் ரீவ்ஸ் , சிற்றலை சிகிச்சை நிறுவனம் , தலைமை மருத்துவ அதிகாரி , மருத்துவ வாழ்க்கைத்தொழில்கள் , சிற்றலை சிகிச்சை , சிகிச்சை நிறுவனம் ,

Ripple Therapeutics Secures Licensing Agreement and Series A Financing led by Théa Open Innovation

Ripple Therapeutics Secures Licensing Agreement and Series A Financing led by Théa Open Innovation
TORONTO, ON / ACCESSWIRE / December 15, 2020 / Ripple Therapeutics Corporation ( Ripple or the Company ), a clinical stage, ophthalmology-focused developer of novel therapeutics, announced today the signing of an exclusive Licensing Agreement for the rights to their lead product, IBE-814, for North America and Europe with Théa Open Innovation ( TOI ) a wholly owned subsidiary of Laboratoires Théa, the leading independent ophthalmology pharmaceutical company in Europe. In addition to the Licensing Agreement, Ripple announced that TOI is leading their Series A Financing.
Ripple s Epidel
® technology platform is founded on a discovery that drugs can be engineered into controlled release pharmaceuticals without the use of polymers or excipients. The proprietary prodrugs have unique properties that allow them to be processed into standalone drug delivery implants (e.g. i ....

United States , New Zealand , Kostenloser Wertpapierhandel , Julie Fotheringham , Tom Reeves , Lorraine Kaltenbach , Business Development Bank , Ripple Therapeutics Corporation , Licensing Agreement , North America , Open Innovation , Ripple Therapeutics , Therapeutics Corporation , North Africa , South America , Media Contact , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஜீலாந்து , டோம் ரீவ்ஸ் , லோரெய்ன் கல்டன்பாக் , வணிக வளர்ச்சி வங்கி , சிற்றலை சிகிச்சை நிறுவனம் , வடக்கு அமெரிக்கா , திறந்த கண்டுபிடிப்பு , சிற்றலை சிகிச்சை , சிகிச்சை நிறுவனம் ,

Ripple Therapeutics Secures Licensing Agreement and Series A Financing led by Thea Open Innovation

Ripple Therapeutics Secures Licensing Agreement and Series A Financing led by Thea Open Innovation
albuquerqueexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from albuquerqueexpress.com Daily Mail and Mail on Sunday newspapers.

United States , New Zealand , Julie Fotheringham , Tom Reeves , Lorraine Kaltenbach , Business Development Bank , Ripple Therapeutics Corporation , Licensing Agreement , North America , Open Innovation , Ripple Therapeutics , Therapeutics Corporation , North Africa , South America , Media Contact , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஜீலாந்து , டோம் ரீவ்ஸ் , லோரெய்ன் கல்டன்பாக் , வணிக வளர்ச்சி வங்கி , சிற்றலை சிகிச்சை நிறுவனம் , வடக்கு அமெரிக்கா , திறந்த கண்டுபிடிப்பு , சிற்றலை சிகிச்சை , சிகிச்சை நிறுவனம் , தெற்கு அமெரிக்கா ,

Ripple Therapeutics Secures Licensing Agreement and Series A Financing led by Théa Open Innovation - Press Release

Ripple Therapeutics Secures Licensing Agreement and Series A Financing led by Théa Open Innovation
TORONTO, ON / ACCESSWIRE / December 15, 2020 / Ripple Therapeutics Corporation ( Ripple or the Company ), a clinical stage, ophthalmology-focused developer of novel therapeutics, announced today the signing of an exclusive Licensing Agreement for the rights to their lead product, IBE-814, for North America and Europe with Théa Open Innovation ( TOI ) a wholly owned subsidiary of Laboratoires Théa, the leading independent ophthalmology pharmaceutical company in Europe. In addition to the Licensing Agreement, Ripple announced that TOI is leading their Series A Financing.
Ripple s Epidel
® technology platform is founded on a discovery that drugs can be engineered into controlled release pharmaceuticals without the use of polymers or excipients. The proprietary prodrugs have unique properties that allow them to be processed into standalone drug delivery implants (e.g. i ....

United States , New Zealand , Julie Fotheringham , Tom Reeves , Lorraine Kaltenbach , Business Development Bank , Ripple Therapeutics Corporation , Licensing Agreement , North America , Open Innovation , Ripple Therapeutics , Therapeutics Corporation , North Africa , South America , Media Contact , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஜீலாந்து , டோம் ரீவ்ஸ் , லோரெய்ன் கல்டன்பாக் , வணிக வளர்ச்சி வங்கி , சிற்றலை சிகிச்சை நிறுவனம் , வடக்கு அமெரிக்கா , திறந்த கண்டுபிடிப்பு , சிற்றலை சிகிச்சை , சிகிச்சை நிறுவனம் , தெற்கு அமெரிக்கா ,